Ligand · TYP
TYP · Cyclo-(L-tyrosine-L-proline) inhibitor
TYP, Cyclo-(L-tyrosine-L-proline) inhibitor (C14 H16 N2 O3, 260.3 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it binds most and the…
- Component
- TYP
- Formula
- C14 H16 N2 O3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
TYP in 2 structures; the first of them:
- 1W1Y · Crystal structure of S. marcescens chitinase B in complex with the cyclic dipeptide… · TYP A1507 · binds TYR10, PHE51, GLY96, TRP97, TYR98, ASP142, GLU144, ALA184 and 9 more
- 1W1Y · Crystal structure of S. marcescens chitinase B in complex with the cyclic dipeptide… · TYP A1507 · binds TYR10, PHE51, GLY96, TRP97, TYR98, ASP142, GLU144, ALA184 and 9 more
Residues it binds most
ASP 14, TRP 12, TYR 12, PHE 12, GLY 10, ARG 8, MET 4, THR 6, ALA 6, LEU 6 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.